Gujarat Inject Key Ratios

BSE: 524238

₹9.72

up-down-arrow-0.18 (-1.82%)

As on 21-Sep-2026 13:00IST

Market cap

info icon

₹144 Cr

Revenue (TTM)

info icon

₹46 Cr

P/E Ratio

info icon

48

P/B Ratio

info icon

11

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -59.43 414.46 151.64 445.22 362.10
EBIT -25.47 1,640.21 286.99 136.52 33.28
Net Profit -23.43 1,638.89 209.51 268.12 78.41
EPS -23.46 1,644.90 209.70 155.88 61.79
Book Value -- -- 392.07 68.41 38.80
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-24Mar-23
EBIT-Margin info -138.81-349.668.410.78-216.96
Net Margin info 3.77-130.406.431.416.77
Return on equity info 1.150.6927.233.440.00
Return on Capital info 0.850.51--2.540.00
Return on Assets info 9.84-126.6712.311.8422.31
Debt to Equity (x) info ----0.000.00-0.73
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
2.54
--
--
--
Peer Median
--
16.46
15.49
17.37
17.62
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

27.23

Higher than Peers by 17.29

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
27.23
3.44
--
--
--
Peer Median
9.94
13.87
14.72
15.70
18.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

12.31

Higher than Peers by 4.77

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
12.31
1.84
22.31
5.37
-664.44
Peer Median
7.54
8.04
7.19
9.43
9.43
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

8.41

Lower than Peers by 0.93

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
8.41
0.78
-216.96
-200.24
-982.24
Peer Median
9.34
10.05
10.28
13.90
17.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

6.43

Lower than Peers by 2.92

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
6.43
1.41
6.77
3.12
-532.90
Peer Median
9.35
9.11
6.78
10.91
12.99
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
1.43
23.62
9.78
-911.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

151.64

Higher than Peers by 145.25

Year on year growth in net sales

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
151.64
3,231.11
668.88
95.67
--
Peer Median
6.38
7.17
10.56
12.63
15.47
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

286.99

Higher than Peers by 288.02

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
286.99
111.90
-733.08
60.11
-2,133.24
Peer Median
-1.03
12.05
6.17
-2.90
51.73
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

209.51

Higher than Peers by 200.47

Year on year growth in profit after tax

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
209.51
101.63
1,757.47
102.10
--
Peer Median
9.04
22.15
27.97
-14.10
44.15
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

209.70

Higher than Peers by 207.64

Year on year growth in earnings per share

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
209.70
-12.74
1,766.67
102.09
--
Peer Median
2.05
8.80
--
-3.68
38.52
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
775.00
4.67
0.25
-13.57
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
--
-0.73
-0.84
-0.79
Peer Median
0.02
0.03
0.05
0.14
0.23
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
--
-0.23
-0.36
-0.31
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.47

Lower than Peers by 2.06

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
0.47
40.77
0.10
0.05
0.02
Peer Median
2.53
2.20
1.93
1.82
1.75
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.47

Lower than Peers by 1.31

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
0.47
40.77
0.10
0.03
0.02
Peer Median
1.78
1.72
1.59
1.30
1.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
237.71
1,108.59
144.19
--
Peer Median
10.23
12.28
12.45
16.98
15.07
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

13.69

Lower than Peers by 12.88

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
13.69
--
--
--
--
Peer Median
26.57
26.23
23.97
24.57
20.26
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.91

Higher than Peers by 1.24

Sales / Average Total Assets

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
1.91
1.29
0.94
0.55
0.73
Peer Median
0.67
0.74
0.88
0.82
0.79
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
--
--
96.48
96.56
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
14.62
765.47
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
-14.62
-765.47
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

47.97

Lower than Peers by 8.79

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
47.97
135.74
93.33
--
--
Peer Median
56.75
39.17
40.74
25.97
33.71
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

10.97

Higher than Peers by 5.93

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
10.97
1.99
-4.57
--
--
Peer Median
5.04
3.61
3.87
2.79
4.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
--
--
--
--
--
Peer Median
0.13
0.19
0.20
0.65
0.28
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

34.90

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
34.90
78.68
78.78
1,889.18
-52.90
Peer Median
--
28.79
25.41
15.07
23.32
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

144

Lower than Peers by 5,814

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-24
Mar-23
Mar-22
Mar-21
Gujarat Inject
144
11
4
--
--
Peer Median
5,957
3,944
2,959
3,742
6,050
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...